Diamyd Medical AB (DMYD B):企業の財務・戦略的SWOT分析

【英語タイトル】Diamyd Medical AB (DMYD B) - Financial and Strategic SWOT Analysis Review

Single User(1名様閲覧用)USD300 ⇒換算¥32,400見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD600 ⇒換算¥64,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥97,200見積依頼/購入/質問フォーム

Diamyd Medical AB (Diamyd), formerly Diamyd Therapeutics AB is a drug development company that offers diabetes vaccine. The company’s diabetes products include Diamyd, an antigen-based immunotherapy for the treatment of autoimmune diabetes. Its pipeline products include GAD, GABA, and other immunomodulatory agents. Diamyd’s GABA or gamma-aminobutyric acid is synthesized from the amino acid glutamate in cells by the enzyme GAD which helps in the regulation of metabolism and the immune system. The company develops treatment for autoimmune diabetes through pharmaceutical development and investments in medical and stem cell technology. Diamyd is headquartered in Stockholm, Sweden.

Diamyd Medical AB Key Recent Developments

Jan 23,2019: Diamyd Medical announces quarterly report I 18/19
Nov 01,2018: Internationally renowned diabetes expert proposed to join Diamyd Medical’s Board of Directors

This comprehensive SWOT profile of Diamyd Medical AB provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Diamyd Medical AB including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.


Table of Contents

Section 1 – About the Company

Diamyd Medical AB – Key Information
Diamyd Medical AB – Overview
Diamyd Medical AB – Key Employees
Diamyd Medical AB – Key Employee Biographies
Diamyd Medical AB – Key Operational Heads
Diamyd Medical AB – Major Products and Services
Diamyd Medical AB – History
Diamyd Medical AB – Company Statement
Diamyd Medical AB – Locations And Subsidiaries
Diamyd Medical AB – Key Manufacturing facilities
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Diamyd Medical AB – Business Description
Diamyd Medical AB – Corporate Strategy
Diamyd Medical AB – SWOT Analysis
SWOT Analysis – Overview
Diamyd Medical AB – Strengths
Diamyd Medical AB – Weaknesses
Diamyd Medical AB – Opportunities
Diamyd Medical AB – Threats
Diamyd Medical AB – Key Competitors

Section 3 – Company Financial Performance Charts

Diamyd Medical AB – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Ratio Definitions
About GlobalData
Contact Us

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Diamyd Medical AB, Key Information
Diamyd Medical AB, Key Ratios
Diamyd Medical AB, Share Data
Diamyd Medical AB, Major Products and Services
Diamyd Medical AB, History
Diamyd Medical AB, Key Employees
Diamyd Medical AB, Key Employee Biographies
Diamyd Medical AB, Key Operational Heads
Diamyd Medical AB, Other Locations
Diamyd Medical AB, Subsidiaries
Diamyd Medical AB, Key Manufacturing facilities
Diamyd Medical AB, Key Competitors
Diamyd Medical AB, SWOT Analysis
Diamyd Medical AB, Ratios based on current share price
Diamyd Medical AB, Annual Ratios
Diamyd Medical AB, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures

Diamyd Medical AB, Performance Chart
Diamyd Medical AB, Ratio Charts

★調査レポート[Diamyd Medical AB (DMYD B):企業の財務・戦略的SWOT分析] (コード:DATA904C14986)販売に関する免責事項を必ずご確認ください。
★調査レポート[Diamyd Medical AB (DMYD B):企業の財務・戦略的SWOT分析]についてメールでお問い合わせ